Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalk

Journal of Bone and Mineral Research

Volumn 25, Issue 10, 2010, Pages 2115-2125

  Cárcamo Orive, Iván ^a   Gaztelumendi, Ainhoa ^a   Delgado, Jesús ^a   Tejados, Naiara ^a   Dorronsoro, Akaitz ^a   Fernández Rueda, Jon ^a   Pennington, Daniel J ^b   Trigueros, César ^a  

^a Foundation for Stem Cell Research   (Spain)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adipose; Bone; Corticosteroid osteoporosis; Osteoblasts and stem cells

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW STROMAL CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; STROMA CELL;

ADIPOGENESIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; OSTEOGENESIS; RECEPTORS, GLUCOCORTICOID; STROMAL CELLS; TRANSCRIPTION FACTOR AP-1;

EID: 77957676301     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.120     Document Type: Article

References (40)

1. Bar-Shavit Z. The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem. 2007;102:1130-1139. (Pubitemid 350220034)
2. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147. (Pubitemid 29282067)
3. Wlodarski KH. Properties and origin of osteoblasts. Clin Orthop Relat Res. 1990;252:276-293.
4. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol. 2006;2:35-43.
5. Duque G. Bone and fat connection in aging bone. Curr Opin Rheumatol. 2008;20:429-434.
6. Minaire P, Neunier P, Edouard C, Bernard J, Courpron P, Bourret J. Quantitative histological data on disuse osteoporosis: comparison with biological data. Calcif Tissue Res. 1974;17:57-73.
7. Zayzafoon M, Gathings WE, McDonald JM. Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis. Endocrinology. 2004;145:2421-2432. (Pubitemid 38535071)
8. Wronski TJ, Walsh CC, Ignaszewski LA. Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone. 1986;7:119-123.
9. Ecklund K, Vajapeyam S, Feldman HA, et al. Bone Marrow Changes in Adolescent Girls with Anorexia Nervosa. J Bone Miner Res. 2009.
10. Wang FS, Ko JY, Yeh DW, Ke HC, Wu HL. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. Endocrinology. 2008;149:1793-1801.
11. Wang GJ, Sweet DE, Reger SI, Thompson RC. Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am. 1977;59:729-735. (Pubitemid 8191201)
12. Sanchez ER, Meshinchi S, Tienrungroj W, Schlesinger MJ, Toft DO, Pratt WB. Relationship of the 90-kDa murine heat shock protein to the untransformed and transformed states of the L cell glucocorticoid receptor. J Biol Chem. 1987;262:6986-6991.
13. Beato M. Gene regulation by steroid hormones. Cell. 1989;56:335-344.
14. Wei P, Inamdar N, Vedeckis WV. Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter. Mol Endocrinol. 1998;12:1322-1333. (Pubitemid 128496194)
15. Vayssiere BM, Dupont S, Choquart A, et al. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol. 1997;11:1245-1255. (Pubitemid 28041332)
16. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol. 1998;12:45-56.
17. Pierotti S, Gandini L, Lenzi A, Isidori AM. Pre-receptorial regulation of steroid hormones in bone cells: insights on glucocorticoid-induced osteoporosis. J Steroid Biochem Mol Biol. 2008;108:292-299. (Pubitemid 351179640)
18. Liu G, Ding W, Liu X, Mulder KM. c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells. Mol Carcinog. 2006;45:582-593. (Pubitemid 44205098)
19. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol. 2003;77:8957-8961. (Pubitemid 36936105)
20. Carcamo-Orive I, Tejados N, Delgado J, et al. ERK2 protein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential. Exp Cell Res. 2008;314:1777-1788.
21. Kang YJ, Jeon ES, Song HY, et al. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem. 2005;95:1135-1145. (Pubitemid 41420121)
22. Neubauer M, Fischbach C, Bauer-Kreisel P, et al. Basic fibroblast growth factor enhances PPARgamma ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett. 2004;577:277-283. (Pubitemid 39452398)
23. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24:462-471. (Pubitemid 44464816)
24. Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell. 1988;55:875-885.
25. Stein B, Angel P, van Dam H, et al. Ultraviolet-radiation induced c-jun gene transcription: two AP-1 like binding sites mediate the response. Photochem Photobiol. 1992;55:409-415.
26. Herber B, Truss M, Beato M, Muller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene. 1994;9:2105-2107.
27. Zhang HY, Young AP. A single upstream glucocorticoid response element juxtaposed to an AP1/ATF/CRE-like site renders the chicken glutamine synthetase gene hormonally inducible in transfected retina. J Biol Chem. 1991;266:24332-24338.
28. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102:274-282.
29. Lian JB, Stein GS. Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med. 1992;3:269-305.
30. Hollinger JO, Hart CE, Hirsch SN, Lynch S, Friedlaender GE. Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am. 2008;90(Suppl 1):48-54.
31. Papachristou DJ, Batistatou A, Sykiotis GP, Varakis I, Papavassiliou AG. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone. 2003;32:364-371. (Pubitemid 36407536)
32. Dass CR, Khachigian LM, Choong PF. c-Jun Is Critical for the Progression of Osteosarcoma: Proof in an Orthotopic Spontaneously Metastasizing Model. Mol Cancer Res. 2008;6:1289-1292.
33. Mariani O, Brennetot C, Coindre JM, et al. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell. 2007;11:361-374.
34. Vig E, Barrett TJ, Vedeckis WV. Coordinate regulation of glucocorticoid receptor and c-jun mRNA levels: evidence for cross-talk between two signaling pathways' at the transcriptional level. Mol Endocrinol. 1994;8:1336-1346.
35. Barrett TJ, Vig E, Vedeckis WV. Coordinate regulation of glucocorticoid receptor and c-jun gene expression is cell type-specific and exhibits differential hormonal sensitivity for down- and up-regulation. Biochemistry. 1996;35:9746-9753.
36. Yang-Yen HF, Chambard JC, Sun YL, et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 1990;62:1205-1215.
37. Schule R, Rangarajan P, Kliewer S, et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell. 1990;62:1217-1226.
38. Jonat C, Rahmsdorf HJ, Park KK, et al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 1990;62:1189-1204.
39. Rosen J, Miner JN. The search for safer glucocorticoid receptor ligands. Endocr Rev. 2005;26:452-464.
40. Coghlan MJ, Jacobson PB, Lane B, et al. A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol Endocrinol. 2003;17:860-869.